CCL22 Induces Pro-inflammatory Changes in Fibroblast-like Synoviocytes

Overview

Journal iScience

Publisher Cell Press

Date 2021 Jan 25

PMID 33490888

Citations 8

Authors

Guomin Ren

Nedaa Al-Jezani

Pamela Railton

James N Powell

Roman J Krawetz

Affiliations

Soon will be listed here.

Abstract

Synovitis is common in patients with osteoarthritis (OA) and is associated with pain and disease progression. We have previously demonstrated that the chemokine C-C motif chemokine 22 (CCL22) induces chondrocyte apoptosis however, the effects of CCL22 on the synovium remain unknown. Therefore, our goal was to investigate the effect of CCL22 on fibroblast-like synoviocytes (FLS). CCL22 treatment suppressed expression of IL-4 and IL-10 and promoted expression of S100A12 in FLS. The response of FLS to CCL22 was not dependent on the disease state of the joint (e.g., normal versus OA), but was instead correlated with the individuals' synovial fluid level of CCL22. CCL22 induction of S100A12 in FLS was attenuated after knockdown of CCR3, yet ligands of CCR3 (CCL7, CCL11) did not induce S100A12 expression. In the presence of CCL22, CCR3-positive FLS upregulate CCL22 and S100A12 driving a potential feedforward pro-inflammatory mechanism distinct from canonical CCL22 and CCR3 pathways.

Citing Articles

FTY720P-treated macrophages in PEG-4MAL hydrogels promote oral wound healing.

Burnham A, Toma A, Shah D, Cha T, Kaimari S, Behara M Cytotherapy. 2024; 27(3):338-349.

PMID: 39665738 PMC: 11810592. DOI: 10.1016/j.jcyt.2024.11.002.

B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma.

Zhong Q, Hao H, Li S, Ning Y, Li H, Hu X J Immunother Cancer. 2024; 12(11).

PMID: 39608978 PMC: 11603694. DOI: 10.1136/jitc-2024-009861.

Edge advances in nanodrug therapies for osteoarthritis treatment.

Liao J, Gu Q, Liu Z, Wang H, Yang X, Yan R Front Pharmacol. 2024; 15:1402825.

PMID: 39539625 PMC: 11559267. DOI: 10.3389/fphar.2024.1402825.

Clinical Significance of Combined Detection of CCL22 and IL-1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma.

Cui L, Song X, Peng Y, Shi M Immun Inflamm Dis. 2024; 12(11):e70043.

PMID: 39508721 PMC: 11542289. DOI: 10.1002/iid3.70043.

Manipulating host secreted protein gene expression: an indirect approach by HPV11/16 E6/E7 to suppress PBMC cytokine secretion.

Zhong M, Xu M, Zheng S, Cheng S, Zeng K, Huang X Virol J. 2024; 21(1):172.

PMID: 39095779 PMC: 11295672. DOI: 10.1186/s12985-024-02432-9.

References

Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

Wang L, Zhang H, Shao L, Chen L, Liu Z, He X . S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis. Biomarkers. 2013; 18(3):216-20. DOI: 10.3109/1354750X.2013.766262. View

Scanzello C . Chemokines and inflammation in osteoarthritis: Insights from patients and animal models. J Orthop Res. 2016; 35(4):735-739. PMC: 5912941. DOI: 10.1002/jor.23471. View

Iyer S, Cheng G . Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012; 32(1):23-63. PMC: 3410706. DOI: 10.1615/critrevimmunol.v32.i1.30. View

Wojdasiewicz P, Poniatowski L, Szukiewicz D . The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014; 2014:561459. PMC: 4021678. DOI: 10.1155/2014/561459. View

Blanpain C, Migeotte I, Lee B, Vakili J, Doranz B, Govaerts C . CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood. 1999; 94(6):1899-905. View

Curiel T, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P . Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004; 10(9):942-9. DOI: 10.1038/nm1093. View

Sokolove J, Lepus C . Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013; 5(2):77-94. PMC: 3638313. DOI: 10.1177/1759720X12467868. View

Atukorala I, Kwoh C, Guermazi A, Roemer F, Boudreau R, Hannon M . Synovitis in knee osteoarthritis: a precursor of disease?. Ann Rheum Dis. 2014; 75(2):390-5. PMC: 4916836. DOI: 10.1136/annrheumdis-2014-205894. View

10.

Zhu X, Liu K, Wang J, Peng H, Pan Q, Wu S . C‑C chemokine receptor type 3 gene knockout alleviates inflammatory responses in allergic rhinitis model mice by regulating the expression of eosinophil granule proteins and immune factors. Mol Med Rep. 2018; 18(4):3780-3790. PMC: 6131541. DOI: 10.3892/mmr.2018.9380. View

11.

Ren G, Whittaker J, Leonard C, De Rantere D, Pang D, Salo P . CCL22 is a biomarker of cartilage injury and plays a functional role in chondrocyte apoptosis. Cytokine. 2019; 115:32-44. DOI: 10.1016/j.cyto.2018.11.030. View

12.

Bochner B, Bickel C, Taylor M, MacGlashan Jr D, Gray P, Raport C . Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner. J Allergy Clin Immunol. 1999; 103(3 Pt 1):527-32. DOI: 10.1016/s0091-6749(99)70481-1. View

13.

Sellam J, Berenbaum F . The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol. 2010; 6(11):625-35. DOI: 10.1038/nrrheum.2010.159. View

14.

Huh Y, Lee G, Song W, Koh J, Ryu J . Crosstalk between FLS and chondrocytes is regulated by HIF-2α-mediated cytokines in arthritis. Exp Mol Med. 2015; 47:e197. PMC: 4686694. DOI: 10.1038/emm.2015.88. View

15.

Imai T, Chantry D, Raport C, Wood C, Nishimura M, Godiska R . Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998; 273(3):1764-8. DOI: 10.1074/jbc.273.3.1764. View

16.

Neogi T . The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage. 2013; 21(9):1145-53. PMC: 3753584. DOI: 10.1016/j.joca.2013.03.018. View

17.

Attur M, Samuels J, Krasnokutsky S, Abramson S . Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol. 2010; 24(1):71-9. DOI: 10.1016/j.berh.2009.08.011. View

18.

Han M, Dai J, Zhang Y, Lin Q, Jiang M, Xu X . Identification of osteoarthritis biomarkers by proteomic analysis of synovial fluid. J Int Med Res. 2013; 40(6):2243-50. DOI: 10.1177/030006051204000622. View

19.

Jablonski C, Leonard C, Salo P, Krawetz R . CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury. J Orthop Res. 2019; 37(12):2561-2574. DOI: 10.1002/jor.24444. View

20.

White J, Lee J, Dede K, Imburgia C, Jurewicz A, Chan G . Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. J Biol Chem. 2000; 275(47):36626-31. DOI: 10.1074/jbc.M006613200. View